Evidence map›Paper›PMID 36014101›Full record

ArticleMicroorganisms2022

Evidence of Community-Wide Spread of Multi-Drug Resistant

Flavien Nsoni Bumbangi, Ann-Katrin Llarena, Eystein Skjerve, Bernard Mudenda Hang'ombe, Prudence Mpundu, Steward Mudenda, Paulin Beya Mutombo, John Bwalya Muma

Abstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Fluoroquinolone Resistance Patterns in Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Antimicrobial resistance profiles ofJAC-antimicrobial resistance · 2024
    Article
  18. Article
  19. Article
  20. A review of the mechanisms that confer antibiotic resistance in pathotypes ofFrontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Flavien Nsoni BumbangiSchool of Medicine, Eden University, Lusaka P.O. Box 37727, Zambia.ORCID 0000-0002-0731-3558
Ann-Katrin LlarenaFaculty of Veterinary Medicine, Norwegian University of Life Sciences, 1432 Ås, Norway.ORCID 0000-0001-5278-7253
Eystein SkjerveFaculty of Veterinary Medicine, Norwegian University of Life Sciences, 1432 Ås, Norway.
Bernard Mudenda Hang'ombeDepartment of Paraclinical Studies, School of Veterinary Medicine, University of Zambia, Lusaka P.O. Box 32379, Zambia.
Prudence MpunduDepartment of Environmental and Occupational Health, Levy Mwanawasa Medical University, Lusaka P.O. Box 33991, Zambia.ORCID 0000-0002-8126-2269
Steward MudendaDepartment of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka P.O. Box 32379, Zambia.ORCID 0000-0003-1692-8981
Paulin Beya MutomboKinshasa School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa 834, Congo.ORCID 0000-0003-4663-9419
John Bwalya MumaDepartment of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka P.O. Box 32379, Zambia.ORCID 0000-0001-6180-4051

Funding

Africa Centre of Excellence for Infectious Disease of Humans and Animals (ACEIDHA) P151847Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education NORPART-2018/10213Wellcome Trust 204954
6 · The paper itself

Abstract

Increased antimicrobial resistance (AMR) has been reported for pathogenic and commensal

Indexed as

antimicrobial resistancechildrenEscherichia colirisk factorsZambia

Identifiers

PMID36014101
PMCPMC9416312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.